E-learning to Prevent Drug Errors in Anesthesia
- Conditions
- Medical Errors : Drugs Errors During Anesthesia
- Registration Number
- NCT03232853
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
The purpose of this observational study is to assess the efficiency of an e-learning in order to put into practice some preventive measures to avoid medication errors during anesthesia.
- Detailed Description
Before the study, the investigators selected 15 preventive measures to avoid medication errors during anesthesia. These measures were learned to the entire anesthesia team (nurse, resident and anesthesiologist) during conventional meetings. An initial evaluation of the application of these measures will be carried out before the introduction of e-learning. This assessment will be conducted by nurses without the knowledge of the anesthetic team evaluated. After this initial evaluation, e-learning will be broadcast on the hospital intranet. Then a second evaluation of the application of the preventive measures will be carried out 6 month and 1 year after the introduction of e-learning.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of application of the preventive measures after versus before the use of an e-learning. 1 day Percentage of application of the preventive measures after versus before the use of an e-learning.
- Secondary Outcome Measures
Name Time Method Evaluation of the application of each of the 15 preventive measureaccording to various clinical parameters 1 day Evaluation of the application of each of the 15 preventive measures according to the clinical parameters of the patients followed (age of the patient, physical state of the ASA, type of surgery, type of anesthesia, period of the day or of the week, surgery of Emergency or elective.)emergency or elective surgery. In each completed questionnaire, these clinical parameters are noted.)
Trial Locations
- Locations (1)
Uhmontpellier
🇫🇷Montpellier, France